A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drug
出版年份 2014 全文链接
标题
A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drug
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 78, Issue 2, Pages 274-281
出版商
Wiley
发表日期
2014-01-17
DOI
10.1111/bcp.12318
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma
- (2012) Tung-Liang Lin et al. ANNALS OF HEMATOLOGY
- The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL
- (2012) C. Muller et al. BLOOD
- Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma
- (2012) P.-C. Tsai et al. CLINICAL CANCER RESEARCH
- Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response
- (2012) U. Jager et al. HAEMATOLOGICA
- Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy
- (2012) S. Angelini et al. HAEMATOLOGICA
- Target Concentration Intervention in Oncology
- (2012) Mohamed Saleem et al. THERAPEUTIC DRUG MONITORING
- Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma
- (2011) David Ternant et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- HomozygousFCGR3A-158Valleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma
- (2011) C. Keane et al. INTERNAL MEDICINE JOURNAL
- Chronic Myeloid Leukemia 2010: Where Are We Now and Where Can We Go?
- (2011) J. P. Radich Hematology-American Society of Hematology Education Program
- Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism
- (2010) Szu-Chin Li et al. AMERICAN JOURNAL OF HEMATOLOGY
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: A report from the BINGO study
- (2010) Yuichi Ishikawa et al. CANCER SCIENCE
- Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
- (2010) Deborah L. White et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
- (2010) Tadeusz Robak et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
- (2010) Ling-Na Ni et al. MEDICAL ONCOLOGY
- Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood
- (2009) Kenneth K. Khamly et al. INTERNATIONAL JOURNAL OF CANCER
- Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials
- (2009) Liat Vidal et al. JNCI-Journal of the National Cancer Institute
- Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
- (2008) S. Dulucq et al. BLOOD
- Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
- (2008) R. A. Larson et al. BLOOD
- Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20
- (2008) D. Dayde et al. BLOOD
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Interaction of Imatinib with Human Organic Ion Carriers
- (2008) S. Hu et al. CLINICAL CANCER RESEARCH
- Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started